(3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide

C27H28N2O8 — CID 137475907

IUPAC(3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide
SMILESCN(C)[C@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@H]4C=C(C5CCC5)O[C@@H]([C@@H]34)[C@@H]12
InChIInChI=1S/C27H28N2O8/c1-29(2)20-19-23-16-12(9-14(37-23)10-5-3-6-10)11-7-4-8-13(30)15(11)21(31)17(16)24(33)27(19,36)25(34)18(22(20)32)26(28)35/h4,7-10,12,16,19-20,23,30-31,34,36H,3,5-6H2,1-2H3,(H2,28,35)/t12-,16+,19+,20+,23-,27-/m0/s1
InChIKeyDSZYFZAVQMFFTC-LRKXYGQQSA-N
MW508.53 g/mol
LogP1.20
Rot. Bonds3

About (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide

(3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide (PubChem CID 137475907) has the molecular formula C27H28N2O8 and a molecular weight of 508.53 g/mol. Its IUPAC name is (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide.

Molecular Properties

Compound Name(3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide
PubChem CID137475907
Molecular FormulaC27H28N2O8
Molecular Weight508.53 g/mol
Exact Mass508.18
IUPAC Name(3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide
SMILESCN(C)[C@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@H]4C=C(C5CCC5)O[C@@H]([C@@H]34)[C@@H]12
InChIInChI=1S/C27H28N2O8/c1-29(2)20-19-23-16-12(9-14(37-23)10-5-3-6-10)11-7-4-8-13(30)15(11)21(31)17(16)24(33)27(19,36)25(34)18(22(20)32)26(28)35/h4,7-10,12,16,19-20,23,30-31,34,36H,3,5-6H2,1-2H3,(H2,28,35)/t12-,16+,19+,20+,23-,27-/m0/s1
InChIKeyDSZYFZAVQMFFTC-LRKXYGQQSA-N
XLogP1.20
TPSA170.62 Ų
H-Bond Donors5
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500508.53
LogP ≤ 51.20
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_4', 'substructure': 'N/A'}

Analyze (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide?
The IUPAC name of (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide (CID 137475907) is (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide.
What is the SMILES notation for (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide?
The canonical SMILES for (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide is CN(C)[C@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)cccc4[C@@H]4C=C(C5CCC5)O[C@@H]([C@@H]34)[C@@H]12.
What is the InChIKey of (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide?
The InChIKey is DSZYFZAVQMFFTC-LRKXYGQQSA-N. The full InChI is InChI=1S/C27H28N2O8/c1-29(2)20-19-23-16-12(9-14(37-23)10-5-3-6-10)11-7-4-8-13(30)15(11)21(31)17(16)24(33)27(19,36)25(34)18(22(20)32)26(28)35/h4,7-10,12,16,19-20,23,30-31,34,36H,3,5-6H2,1-2H3,(H2,28,35)/t12-,16+,19+,20+,23-,27-/m0/s1.
What are the key properties of (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide?
(3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide has a molecular weight of 508.53 g/mol, XLogP of 1.20, 3 rotatable bonds, 5 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,7R,8R,9S,13S,21R)-11-cyclobutyl-7-(dimethylamino)-3,4,18,20-tetrahydroxy-2,6-dioxo-10-oxapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1(20),4,11,14(19),15,17-hexaene-5-carboxamide is sourced from PubChem (CID 137475907), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).